2007D-0021
  

  
  Guidance for Industry; Advisory Committee Meetings: Preparation and Public Availability of Information Given to Advisory Committee Members

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC4
  



  

  
Submitter : 
  

  
Ms. Lynley Thinnes
  

  
Date & Time: 
  

  
05/01/2007 10:05:36
  



  

  
Organization : 
  

  
AstraZeneca LP
  



  

  
Category : 
  

  
Drug Industry
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
See attachment
  


  

  



  

  
2007D-0021-EC4-Attach-1.PDF